Keywords: Aguettant. PX'Therapeutics, M&D, Contract manufacuring

French drugmaker Aguettant takes majority stake in PX'Therapeutics

Article | 03 October 2012

Print This

Aguettant Sante, a French biotechnology pioneer in drugs for injection since 1903, has acquired a majority stake in the equity of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in